Xiaoyong Fu Selected Research

endonuclease R

10/2016

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyong Fu Research Topics

Disease

28	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2010
24	Neoplasms (Cancer) 01/2022 - 01/2010
2	Cardiac Arrhythmias (Arrythmia) 12/2018 - 09/2014
2	Hepatocellular Carcinoma (Hepatoma) 06/2005 - 09/2004
1	Hypoxia (Hypoxemia) 12/2019
1	Carcinogenesis 06/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Genomic Instability 07/2008
1	Carcinoma (Carcinomatosis) 09/2004
1	Cholangiocarcinoma 09/2004
1	Dehydration (Water Stress) 06/2002

Drug/Important Bio-Agent (IBA)

16	Estrogen ReceptorsIBA 01/2022 - 01/2010
9	Tamoxifen FDA LinkGeneric 01/2020 - 04/2014
8	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2010
5	Fulvestrant (Faslodex)FDA Link 01/2020 - 04/2014
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
4	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2005
4	Estrogens (Estrogen)FDA Link 01/2020 - 09/2015
4	ChromatinIBA 01/2020 - 04/2011
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2018
3	Lapatinib (GW572016)FDA Link 11/2019 - 01/2011
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2022 - 01/2019
2	Hormones (Hormone)IBA 01/2020 - 01/2019
2	TensinsIBA 01/2020 - 09/2014
2	Biological ProductsIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 03/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 09/2014
2	Trastuzumab (Herceptin)FDA Link 11/2019 - 01/2011
2	LigandsIBA 01/2018 - 04/2014
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2016 - 04/2011
2	ErbB Receptors (EGF Receptor)IBA 09/2015 - 07/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2014 - 01/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2014 - 08/2013
2	human ERBB2 proteinIBA 09/2014 - 01/2011
1	InterferonsIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	CytokinesIBA 01/2022
1	Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA 01/2022
1	palbociclibIBA 01/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	Green Fluorescent ProteinsIBA 01/2020
1	Red Fluorescent ProteinIBA 01/2020
1	Differentiation AntigensIBA 01/2020
1	Doxycycline (Periostat)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Mevalonic Acid (Mevalonate)IBA 11/2019
1	Simvastatin (Zocor)FDA LinkGeneric 11/2019
1	Zoledronic Acid (Zometa)FDA Link 11/2019
1	AZD9496IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 07/2018
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2018
1	Stem Cell FactorIBA 01/2017
1	SOX9 Transcription FactorIBA 01/2017
1	endonuclease RIBA 10/2016
1	Interleukin-8 (Interleukin 8)IBA 10/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2014
1	TOR Serine-Threonine KinasesIBA 09/2014
1	Estrogen Receptor alphaIBA 07/2014
1	MethyltransferasesIBA 07/2014
1	Histones (Histone)IBA 07/2014
1	AZD 8931IBA 04/2014
1	A-factor (Streptomyces)IBA 06/2013
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2013
1	phosphoinositide-3,4,5-triphosphateIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 07/2011
1	UbiquitinIBA 03/2010
1	Messenger RNA (mRNA)IBA 01/2010
1	Growth Factor ReceptorsIBA 01/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2010
1	Lysine (L-Lysine)FDA Link 07/2008
1	Oncogene Proteins (Oncogene Protein)IBA 06/2005
1	ParaffinIBA 09/2004
1	Keratin-18 (Keratin 18)IBA 09/2004
1	Formaldehyde (Formol)FDA Link 09/2004
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2002

Therapy/Procedure

17	Therapeutics 01/2022 - 01/2010
2	Radiofrequency Ablation 12/2018 - 09/2014
1	Catheters 12/2018
1	Heterologous Transplantation (Xenotransplantation) 03/2011